Last reviewed · How we verify
NCT03877497: TRUST
To Reach Unrestricted Services for Transgender Women
NA trial testing Adapted SBIRT-T for transgender women in Transgender Women in 86 participants. Completed in 4 December 2024.
31 May 2024
Quick facts
| Lead sponsor | University of Central Florida |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 86 |
| Start date | 19 September 2019 |
| Primary completion | 31 May 2024 |
| Estimated completion | 4 December 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Adapted SBIRT-T for transgender women
Conditions studied
- Transgender Women — all drugs for Transgender Women →
- Substance Abuse — all drugs for Substance Abuse →
- Hiv — all drugs for Hiv →
Sponsor
University of Central Florida
Who can join
18 and older, male only, with Transgender Women or Substance Abuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Florida has the fifth largest transgender population in the United States. Transgender women, particularly those of color, in the southern part of Florida are a marginalized population who are impacted by co-morbidities of substance abuse and HIV in their communities. The overall objective of the study is to use a vetted adapted brief intervention to stem the development of substance abuse in at-risk transgender women, and thereby increase primary and secondary prevention methods such as routine HIV screening, uptake of pre-exposure prophylaxis (PrEP) and use of non-occupational post-exposure prophylaxis (nPEP).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03877497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Central Florida trials
Trials by the same sponsor.
- NCT07203430 — Biopsychosocial Factors and Muscle Morphology After a Resistance Exercise · NA · completed
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT06999057 — Quadriceps Motor Unit Adaptation to Simulated Knee Injury · NA · not yet recruiting
- NCT06979713 — Yoga, Education, and Nidra (YEN) for Chronic Low Back Pain: A Pilot Study on Pain Modulation, Well-Being, and Sleep · NA · not yet recruiting
- NCT06512168 — Measuring Aided Language Development · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03877497 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Central Florida
- Last refreshed: 10 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03877497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing